Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogsShaohang Cai, Jie Peng, Muye Xia et al.|Infection and Drug Resistance|2018Cited by 43
A noninvasive diagnostic model to assess nonalcoholic hepatic steatosis in patients with chronic hepatitis BHongjie Ou, Jie Peng, Shaohang Cai et al.|Therapeutic Advances in Gastroenterology|2016Cited by 41
Effectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection pre-treated with interferon compared with de novo therapy with entecavir and telbivudineShaohang Cai, Jie Peng, Jiawei Cao et al.|Medicine|2017Cited by 34
<p>Serum Hepatitis B Virus RNA Levels Predict HBeAg Seroconversion and Virological Response in Chronic Hepatitis B Patients with High Viral Load Treated with Nucleos(t)ide Analog</p>Xin Ji, Jie Peng, Muye Xia et al.|Infection and Drug Resistance|2020Cited by 23
Soluble Programmed Cell Death-1 is a Novel Predictor of HBsAg Loss in Chronic Hepatitis B Patients When Long-Term Nucleos(t)ide Analog Treatment is DiscontinuedGuichan Liao, Jie Peng, Xiaoyong Zhang et al.|Infection and Drug Resistance|2022Cited by 6